[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ocular Therapeut (OCUL)

Ocular Therapeut (OCUL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,065,897
  • Shares Outstanding, K 217,692
  • Annual Sales, $ 51,950 K
  • Annual Income, $ -265,940 K
  • EBIT $ -270 M
  • EBITDA $ -266 M
  • 60-Month Beta 0.95
  • Price/Sales 40.19
  • Price/Cash Flow N/A
  • Price/Book 3.15

Options Overview Details

View History
  • Implied Volatility 109.19% (+2.19%)
  • Historical Volatility 69.75%
  • IV Percentile 82%
  • IV Rank 19.92%
  • IV High 363.10% on 02/13/26
  • IV Low 46.01% on 08/22/25
  • Expected Move (DTE 6) 1.12 (11.82%)
  • Put/Call Vol Ratio 0.32
  • Today's Volume 841
  • Volume Avg (30-Day) 1,952
  • Put/Call OI Ratio 0.19
  • Today's Open Interest 46,218
  • Open Int (30-Day) 75,393
  • Expected Range 8.37 to 10.61

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $-0.32
  • Number of Estimates 6
  • High Estimate $-0.30
  • Low Estimate $-0.32
  • Prior Year $-0.37
  • Growth Rate Est. (year over year) +13.51%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.38 +28.59%
on 03/30/26
9.86 -3.75%
on 04/17/26
+1.39 (+17.16%)
since 03/24/26
3-Month
6.23 +52.32%
on 02/17/26
11.50 -17.48%
on 03/03/26
-0.78 (-7.59%)
since 01/23/26
52-Week
6.23 +52.32%
on 02/17/26
16.44 -42.27%
on 12/08/25
+1.59 (+20.13%)
since 04/24/25

Most Recent Stories

More News
Ocular Therapeutix™ to Host Investor Day on June 17, 2026

BEDFORD, Mass., April 22, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, today...

OCUL : 9.49 (-1.04%)
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BEDFORD, Mass., April 14, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular” or the “Company”), an integrated biopharmaceutical company committed to redefining the retina...

OCUL : 9.49 (-1.04%)
Ocular Therapeutix™ Announces Additional Positive Week 52 Data from Landmark SOL-1 Phase 3 Trial of AXPAXLI™ in Wet AMD

New SOL-1 post-hoc analyses presented at VBS reinforce AXPAXLI’s unmatched durability in wet AMD with sustained disease control AXPAXLI demonstrated robust CSFT control with a median time of 39...

OCUL : 9.49 (-1.04%)
1 Healthcare Stock with Exciting Potential and 2 Facing Headwinds

1 Healthcare Stock with Exciting Potential and 2 Facing Headwinds

GH : 88.91 (+1.18%)
VRTX : 430.29 (-1.11%)
OCUL : 9.49 (-1.04%)
Ocular Therapeutix™ to Present Additional SOL-1 Data and Analyses at Upcoming Scientific Conferences in April

BEDFORD, Mass., April 01, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, today...

OCUL : 9.49 (-1.04%)
1 Cash-Heavy Stock to Research Further and 2 We Brush Off

1 Cash-Heavy Stock to Research Further and 2 We Brush Off

FG : 27.99 (+2.19%)
LZ : 6.31 (+0.96%)
OCUL : 9.49 (-1.04%)
3 Reasons to Avoid OCUL and 1 Stock to Buy Instead

3 Reasons to Avoid OCUL and 1 Stock to Buy Instead

OCUL : 9.49 (-1.04%)
3 Stocks Under $10 We Think Twice About

3 Stocks Under $10 We Think Twice About

DBI : 8.11 (-1.82%)
AHCO : 12.80 (+0.55%)
OCUL : 9.49 (-1.04%)
Pharmaceuticals Stocks Q4 Highlights: Ocular Therapeutix (NASDAQ:OCUL)

Pharmaceuticals Stocks Q4 Highlights: Ocular Therapeutix (NASDAQ:OCUL)

OCUL : 9.49 (-1.04%)
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BEDFORD, Mass., March 09, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, today...

OCUL : 9.49 (-1.04%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Ocular Therapeutix, Inc. is a biopharmaceutical company. It is focused on the development and commercialization of ophthalmic therapeutic products using its proprietary hydrogel technology to address unmet or underserved needs in ophthalmology. The Company develops and markets eye care products. Ocular...

See More

Key Turning Points

3rd Resistance Point 9.91
2nd Resistance Point 9.77
1st Resistance Point 9.63
Last Price 9.49
1st Support Level 9.35
2nd Support Level 9.22
3rd Support Level 9.08

See More

52-Week High 16.44
Fibonacci 61.8% 12.54
Fibonacci 50% 11.34
Fibonacci 38.2% 10.13
Last Price 9.49
52-Week Low 6.23

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.